Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 182

The DOI matches its Crossref record.

Structural basis for the high all-trans -retinaldehyde reductase activity of the tumor marker AKR1B10

Open access
Gallego, Oriol, Ruiz, F. Xavier, Ardèvol, Albert, Domínguez, Marta, Alvarez, Rosana, de Lera, Angel R., Rovira, Carme, Farrés, Jaume, Fita, Ignacio, Parés, Xavier · 2007 · Proceedings of the National Academy of Sciences

Abstract

AKR1B10 is a human aldo-keto reductase (AKR) found to be elevated in several cancer types and in precancerous lesions. In vitro , AKR1B10 exhibits a much higher retinaldehyde reductase activity than any other human AKR, including AKR1B1 (aldose reductase). We here demonstrate that AKR1B10 also acts as a retinaldehyde reductase in vivo . This activity may be relevant in controlling the first step of retinoic acid synthesis. Up-regulation of AKR1B10, resulting in retinoic acid depletion, may lead to cellular proliferation. Both in vitro and in vivo activities of AKR1B10 were inhibited by tolrestat, an AKR1B1 inhibitor developed for diabetes treatment. The crystal structure of the ternary complex AKR1B10–NADP + –tolrestat was determined at 1.25-Å resolution. Molecular dynamics models of AKR1B10 and AKR1B1 with retinaldehyde isomers and site-directed mutagenesis show that subtle differences at the entrance of the retinoid-binding site, especially at position 125, are determinant for the all-trans -retinaldehyde specificity of AKR1B10. Substitutions in the retinaldehyde cyclohexene ring also influence the specificity. These structural features should facilitate the design of specific inhibitors, with potential use in cancer and diabetes treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0705659105

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 182

Metadata

Authors
Gallego, O., Ruiz, F. X., Ardèvol, A., Domínguez, M., Alvarez, R., de Lera, A. R., Rovira, C., Farrés, J., Fita, I., & Parés, X.
Venue
Proceedings of the National Academy of Sciences
Published
2007-12-26
Volume
104
Issue
52
Pages
20764-20769
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2009940306
Cited by
182
References
0
FWCI
3.35
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structural basis for the high all-trans -retinaldehyde reductase activity of the tumor marker AKR1B10. https://app.cochat.ai/papers/10.1073/pnas.0705659105
The paper
Gallego, O., Ruiz, F. X., Ardèvol, A., Domínguez, M., Alvarez, R., de Lera, A. R., Rovira, C., Farrés, J., Fita, I., & Parés, X. (2007). Structural basis for the high all-trans -retinaldehyde reductase activity of the tumor marker AKR1B10. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0705659105

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.